1.Investigation on Drug Utilization and Safe Medication in Gestational Patients of a Hospital
China Pharmacy 2007;0(29):-
OBJECTIVE:To evaluate the drug utilization and safe medication in gestational women in a hospital. METHODS: The drug utilization in 505 gestational women in a hospital from July 2007 to Jan. 2008 was investigated,with FDA's drug classification system during gestation as control. RESULTS & CONCLUSION: 35.84% of the patients received drugs during gestation;54.01% used drugs in the first 3 gestational months;56.15% used at least 2 kinds of drugs in combination;traditional Chinese medicine or Chinese patent medicines were the first choice for gestational women. The drug use for gestational women was prudent and basically in line with FDA's drug classification system during gestation;however,some drugs which pose risks for fetus were also used. There is as yet no guiding principle for safe medication of gestational women in China,thus it is imperative to establish safe drug use system for gestational women.
3.Analysis on relation between viral genome with hepatitis B virus e antigen and liver function in chronic hepatitis B patients
Zhenjie LIU ; Yongjian CAO ; Zihua CEN ; Ning XU
International Journal of Laboratory Medicine 2016;37(13):1784-1786
Objective To study the relationship among hepatitis B viral genome (HBV‐DNA) ,hepatitis Be antigen(HBeAg) and liver function in chronic hepatitis B patients ,and to provide the reference for clinical treatment .Methods The quantitative levels of HBV‐DNA ,HBeAg ,alanine aminotransferase (ALT) and aspartate aminotransferase(AST) in 401 patients were analyzed and the correlation analysis between HBV‐DNA and HBeAg was performed .The grouping was performed according to the HBV‐DNA and HBeAg quantitative levels and the differences of ALT and AST levels were compared among the groups .Results (1) The correla‐tion existed between HBV‐DNA and HBeAg positive rate ,r=0 .671(P<0 .01);(2)when HBV‐DNA load reaching 105 copies/mL , serum ALT and AST levels showed significantly increased compared with the HBV‐DNA negative group and low load group ,the difference was statistically significant (P<0 .05);(3)when HBV‐DNA load was equivalent ,the difference of ALT and AST activity had no statistically significant difference between the HBeAg‐positive and HBeAg‐negative groups .Conclusion (1)HBeAg has a correlation with HBV‐DNA ;(2)the patients with higher HBV‐DNA load are easy to develop the liver function abnormality ;(3)the HbeAg existence situation has no obvious relation with the liver function .
4.Value of lactulose hydrogen breath test combined with radionuclide imaging in the diagnosis of small intestinal bacterial overgrowth
Ni HOU ; Yanli NING ; Dongfang CHEN ; Cen LOU
Chinese Journal of Nuclear Medicine and Molecular Imaging 2017;37(8):478-481
Objective To compare the tracing effects of radionuclide and barium sulfate on lactulose hydrogen breath test (LHBT), and to explore the value of LHBT combined with radionuclide imaging in the diagnosis of small intestinal bacterial overgrowth (SIBO) in patients with irritable bowel syndrome (IBS).Methods From November 2010 to November 2012, 89 patients (47 males, 42 females;mean age (45.7±12.9) years) with IBS and 13 healthy volunteers (9 males, 4 females;mean age (43.3±8.6) years) were enrolled in this prospective study.All the subjects underwent LHBT combined with radionuclide imaging.Recording the time when the increment of H2 value >0.005‰ and the OCTT of the radionuclide.Four healthy volunteers also underwent LHBT combined with barium sulfate 1 week after radionuclide imaging.The location of barium sulfate was recorded when H2 value increment >0.020‰.Patients with SIBO received rifaximin treatment, and the effect was observed.χ2 test, Pearson correlation analysis and Wilcoxon rank sum test were used to analyze the data.Results (1)In LHBT combined with barium sulfate test, barium sulfate was found still stagnating in small intestine by abdominal X-ray when H2 value increment >0.020‰ in 4 healthy volunteers, and barium sulfate didn′t reach the colon in delayed imaging in 1 patient.(2) The rates of SIBO detected by LHBT in IBS patients and healthy volunteers were significantly different (43.8%(39/89) vs 5/13;χ2=0.133, P=0.716), and those detected by LHBT combined with radionuclide imaging were also significantly different (39.3%(35/89) vs 1/13;χ2=4.970, P=0.026).(3)The time of H2 value increased >0.005‰ correlated well with OCTT in 13 healthy volunteers ((73±31) and (50±19) min;r=0.871, P<0.001) and 54 IBS patients without SIBO ((83±34) and (66±28) min;r=0.735, P<0.001), but there was no correlation in 35 IBS patients with SIBO ((36±30) and (75±30) min;r=0.304, P=0.076).(4)A total of 34 SIBO-positive patients received a rifaximin treatment, with a significant improvement in the frequency of abdominal pain and abdominal distension after the treatment according to Rome Ⅲ diagnostic criteria: 5(4, 6) vs 4(3, 5), 4(1, 6) vs 0(0, 4)(z values:-4.842 and-5.388, both P<0.001).Conclusion LHBT alone is not a valid test for SIBO, and LHBT combined with radionuclide imaging is a good candidate for SIBO diagnosis.
5.Applications of platelets in studies on traditional Chinese medicines promoting blood circulation to remove blood stasis.
Feng-Qin WANG ; Cen CHEN ; Zhi-Ning XIA ; Feng-Qing YANG
China Journal of Chinese Materia Medica 2014;39(16):2993-3003
Thrombotic diseases in different forms become a great threat to human health. Such anti-platelet aggregation drugs as aspirin and clopidogrel are common drugs in clinic. However, along with the appearance of resistance and side effects of western anti-platelet aggregation drugs, anti-platelet aggregation traditional Chinese medicines promoting blood circulation to remove blood stasis have gradually become an important study orientation. Platelet is one of major participant in thrombosis, and plays an important role as a bioactive material in studies on traditional Chinese medicines promoting blood circulation to remove blood stasis, mainly involving two aspects--the evaluation for the anti-platelet aggregation activity of traditional Chinese medicines and the screening of their active components. This paper summarized the applications of platelets in studies on traditional Chinese medicines promoting blood circulation to remove blood stasis, so as to provide basis for further studies.
Animals
;
Blood Circulation
;
drug effects
;
Blood Platelets
;
drug effects
;
physiology
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Thrombosis
;
drug therapy
;
physiopathology
6.Research progress of pharmacological activities and analytical methods for plant origin proteins.
Chun-hong LI ; Cen CHEN ; Zhi-ning XIA ; Feng-qing YANG
China Journal of Chinese Materia Medica 2015;40(13):2508-2517
As one of the important active components of traditional Chinese medicine (TCM), plant origin active proteins have many significant pharmacological functions. According to researches on the plant origin active proteins reported in recent years, pharmacological effects include anti-tumor, immune regulation, anti-oxidant, anti-pathogeny microorganism, anti-thrombus, as well as hypolipidemic and hypoglycemic activities of plant origin were reviewed, respectively. On the other hand, the analytical methods including chromatography, spectroscopy, electrophoresis and mass spectrometry for plant origin proteins analysis were also summarized. The main purpose of this paper is providing a reference for future development and application of plant active proteins.
Animals
;
Antineoplastic Agents, Phytogenic
;
pharmacology
;
Antioxidants
;
pharmacology
;
Fibrinolytic Agents
;
pharmacology
;
Humans
;
Hypoglycemic Agents
;
pharmacology
;
Immunologic Factors
;
pharmacology
;
Plant Proteins
;
analysis
;
pharmacology
;
Research
7.Driver gene status and first line treatment of advanced lung adenocarcinoma:A single centric real-world study
Ning SU ; Xianlan ZHANG ; Huiyi HUANG ; Yun JIN ; Yalin XIE ; Wei ZHOU ; Jingrong HE ; Wen-Chang CEN
The Journal of Practical Medicine 2019;35(4):537-540
Objective To analyze driver genes status and its clinical characteristics of advanced lung adenocarcinoma, then evaluate the status of first-line treatment in a single centric real-world. Methods EGFR, ALK, ROS-1 gene in 204 advanced lung adenocarcinoma tissue were tested by ARMS-PCR method. And the relationship between driver genes status and clinical characteristics was analyzed as the first line treatment in real clinical practice. Results The positive rate of driver genes status in 204 advanced lung adenocarcinoma was 53.9% (110/204) , including EGFR mutation 46.1% (94/204) , ALK positive 6.4% (13/204) and ROS1 positive 1.5% (3/204). The driving genes status was significantly correlated with gender, smoking history, tumor staging and serosal invasion (P < 0.05). There were significantly differences among the proportion of first-line standard treatment in different subgroup (P = 0.000) , the first-line standard treatment rate of EGFR mutation, ALK/ROS1 positive and drive gene negative were 77.7%, 37.5%, and 46.8% respectively. And the ratio of using 1 st generation EGFR-TKIs in all patients is 70.6% (60/85). Conclusion More than half of advanced lung adenocarcinoma have driver genes changes, and EGFR-TKI first-line treatment has higher acceptability in real-word.
8.Dysbiosis of lung commensal bacteria in the process of lung epithelial-mesenchymal transition in mice with silicosis
China Occupational Medicine 2022;49(05):514-
Objective -
To investigate the effect of lung flora dysbiosis on the process of pulmonary fibrosis and lung epithelial
( ) Methods -
mesenchymal transition EMT in mice with silicosis. Male C57BL/6 mice of specific pathogen free grade were
, , , ( )
randomly divided into the blank control group silicosis model group solvent control group vancomycin VM + ampicillin
( ) , ( ) ( ) ,
AMP group metronidazole MNZ + neomycin NEO group and mixed treatment group 12 mice in each group. Except for
, ,
the blank control group which was given 20.0 µL of 0.9% NaCl solution the other five groups of mice were dosed with 20.0 µL
of silica dust suspension at a mass concentration of 250.0 g/L using a single tracheal drip to establish the silicosis mouse model.
:
The intranasal drip method was used to treat silicosis mice in each group as following mice in the solvent control group were
- ; ;
given double distilled water mice in the VM+AMP group were given VM at a mass concentration of 0.5 g/L and AMP at 1.0 g/L
;
mice in the MNZ+NEO group were given MNZ at a mass concentration of 1.0 g/L and NEO at 1.0 g/L mice in the mixed
,
treatment group were given the same doses of the four antibiotics mentioned above all in a drip volume of 50.0 µL. Silicosis
, ,
mice were treated seven days and half an hour before silica dusting and 7 14 and 21 days after silica dusting. Mouse lungtissue was collected aseptically 28 days after silica dusting. Hematoxylin eosin and Masson trichrome staining methods were
-
used to observe the pathological changes. Western blotting was used to detect the relative protein expression of α smooth muscle
( - ), - ( - ) ( )
actin α SMA E cadherin E CAD and vimentin VIM . Immunohistochemistry was used to detect the relative expression of
- -
E CAD and VIM. Real time fluorescence quantitative polymerase chain reaction was used to detect the expression levels of
(Col1a2) Results
collagen type Ⅰ alpha 2 mRNA in lung tissues. The histopathological results showed that the alveoli of the
,
blank control group were thin and structurally intact with few surrounding infiltrating inflammatory cells and no abnormal
,
distribution of collagen fibers. The alveoli of the silicosis model group were structurally disorganized with a large number of
, ,
infiltrating inflammatory cells thickened alveolar walls and cellular fibrous nodules with abundant blue collagen deposit. In the
, ,
VM+AMP group MNZ+NEO group and the mixed treatment group the inflammation and fibrosis were reduced with diferent
degrees in the lung tissues compared to the silicosis model group and the solvent control group. The relative expression levels of
- , Col1a2
α SMA VIM protein and mRNA in lung tissues of mice in the silicosis model group were higher than those in the blank
( P ), -CAD
control group all <0.05 and the relative expression levels of E protein were lower than those in the blank control
(P ) - , Col1a2
group <0.05 . The relative expression levels of α SMA VIM protein and mRNA in lung tissues of mice in the MNZ+
( P ), -CAD
NEO group and the mixed treatment group were lower all <0.05 and the relative expression levels of E protein were
(P ), Conclusion
higher <0.05 when compared with the silicosis model group and the solvent control group. Pulmonary fibrosis
, -
was reduced in silicosis mice with interventions in lung flora where anaerobic and gram negative bacteria affected pulmonary
fibrosis and dysbiosis of the lung flora affected pulmonary EMT.
9.Identification of HBV genotype-specific tag sequences.
Ying CAI ; Xue-cheng LI ; Xiao-mei WU ; Ning WANG ; Hong-wei CAO ; Guo WEI ; Ke-cen ZHAO ; Kai ZHENG ; Jiang ZHENG ; Yan LI
Chinese Journal of Hepatology 2010;18(2):101-104
OBJECTIVETo identify the HBV genotype-specific tag sequence.
METHODSThe large S region sequences from 930 HBV genomes were aligned to identify the genotype-specific tag sequences. PCR was used to check the genotyping effect of these tags.
RESULTSTwo tag sequences, sequence between 149-169 and sequence between 461-483, were identified in the large S region. Using primers specific to these tag sequences, the genotype of HBV can be specifically identified.
CONCLUSIONThese tag sequences can be used for HBV genotyping.
Base Sequence ; DNA Primers ; Gene Library ; Genes, Viral ; Genotype ; Hepatitis B virus ; classification ; genetics ; Hepatitis B, Chronic ; virology ; Humans ; Molecular Sequence Data ; Polymerase Chain Reaction ; methods ; Protein Precursors ; genetics ; Sequence Analysis, DNA
10.Comparison of different cryopreservation systems for peripheral blood stem cells.
You-Zhang HUANG ; Jian-Liang SHEN ; Ping-Di YANG ; Nan-Hai WU ; Xiang-Feng TANG ; Li-Zhong GONG ; Jian CEN ; Li-Xin WANG ; Ning WANG ; Pei-Hao ZHENG
Chinese Journal of Applied Physiology 2008;24(1):125-128
AIMTo explore proper cryopreservative systems for hematopoietic stem cells.
METHODSPeripheral blood mononuclear cells from 20 persons were mixed with different cryopreservative agent, dimethyl suflfoxide (DMSO) or combination of DMSO and hydroxyethyl starch (HES), then cooled in -80 degrees C low temperature refrigerator (Refr) or autocontrolled programmed cryogenic system (PCS), preserved in Refr or in liquid nitrogen. GM-CFU, LTC-IC, CD34+ cells and typeran blue resistance (TBR) were assayed after different period of cryopreservation.
RESULTSThe recovery rates of CFU-GM, LTC-IC, CD34+ cells and TBR in peripheral blood mononuclear cells which were cooled and preserved in Refr with 5% DMSO-6% HES were 82.2% +/- 14.7%, 83.0% +/- 12.2%, 94.2% +/- 4.3% and 97.7% +/- 3.9% respectively, significantly higher than that in Refr with 10% DMSO (P < 0.05). When cells were cryopreservated with the same cryopreservatives, there was no significantly difference of recovery rate in group of Refr and group of Refr with PCS. Meanwhile, there was not significantly difference of recovery rate among all three groups, preserved in Refr ahead of liquid nitrogen, in Refr merely, in liquid nitrogen with PCS within one year (p > 0.05). However, the recovery rate of CFU-GM, LTC- IC, CD34+ cells and TBR decreased dramatically if cells were cooled and preserved in Refr for two years. After cells were thawed, the cell activity declined gradually at room temperature if the cryopreservatives were not removed or diluted. The cell activity of 10% DMSO group was affected more than that of 5% DMSO-6% HES group.
CONCLUSION5% DMSO-6% HES is better than 10% DMSO as cryopreservatives for hematopoietic stem cells. Refr cryopreservation is a simple and effective method if cells would be cryopreserved for less than one year. If cells would be cryopreserved for more than one year, liquid nitrogen cryopreservation should be recommended. The cryopreservatives should be diluted or removed immediately after cells were thawed.
Blood Preservation ; methods ; Cell Survival ; drug effects ; Cryopreservation ; methods ; Cryoprotective Agents ; pharmacology ; Hematopoietic Stem Cell Transplantation ; methods ; Hematopoietic Stem Cells ; cytology ; drug effects ; Humans